ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

29,800Medicare Part D Prescriptions Filled, Including Refills

Rank: 39 out of 3593

$2.12M Total Retail Price of All Prescriptions

Rank: 16 out of 3593

555 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
81% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

6% of this provider’s 555 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 27,794 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

37% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$71 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

54 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
OMEPRAZOLE 1,151 1,060 1 5
SIMVASTATIN 940 877 2 1
AMLODIPINE BESYLATE 923 883 3 3
CRESTOR 916 854 4 21
LISINOPRIL 744 680 5 2
RANITIDINE HCL 614 590 6 27
NEXIUM 597 555 7 36
ATENOLOL 508 493 8 11
FENOFIBRATE 497 464 9 39
METOPROLOL SUCCINATE 478 455 10 19
FUROSEMIDE 470 445 11 9
METOPROLOL TARTRATE 446 418 12 8
BENICAR 411 378 13 131
LEVOTHYROXINE SODIUM 389 381 14 4
ALENDRONATE SODIUM 386 360 15 22
GABAPENTIN 384 357 16 16
BENICAR HCT 360 340 17 155
METFORMIN HCL 359 338 18 6
NAMENDA 336 324 19 50
LOSARTAN POTASSIUM 332 311 20 14
MELOXICAM 325 310 21 29
DICLOFENAC SODIUM 323 305 22 74
IBUPROFEN 317 294 23 43
VOLTAREN 305 290 24 85
ADVAIR DISKUS 296 253 25 47
LIDODERM 290 267 26 78
PLAVIX 285 273 27 42
ESCITALOPRAM OXALATE 284 268 28 71
LOVAZA 277 238 29 106
ZOLPIDEM TARTRATE 276 245 30 12
SYMBICORT 275 272 31 160
CLOPIDOGREL 270 260 32 30
CARVEDILOL 265 244 33 23
SINGULAIR 263 252 34 77
FLUTICASONE PROPIONATE 243 217 35 32
DEXILANT 227 193 36 222
ALPRAZOLAM 221 217 37 37
DIOVAN HCT 218 209 38 76
GLIMEPIRIDE 205 197 39 44
JANUVIA 204 195 40 81
LEXAPRO 191 185 41 184
AMLODIPINE BESYLATE-BENAZEPRIL 187 182 42 65
GLYBURIDE-METFORMIN HCL 184 169 R 43 95
PROAIR HFA 184 166 43 54
ALLOPURINOL 184 174 43 35
DIOVAN 183 167 46 46
ATORVASTATIN CALCIUM 181 181 47 15
AVODART 177 174 48 180
DICYCLOMINE HCL 176 162 49 190
TRAMADOL HCL 176 164 49 17
CLONIDINE HCL 174 165 51 41
TRICOR 173 152 52 130
GLIPIZIDE ER 165 162 53 101
CLOBETASOL PROPIONATE 164 160 54 187
LOSARTAN-HYDROCHLOROTHIAZIDE 160 130 55 48
CLONAZEPAM 158 153 56 164
DONEPEZIL HCL 152 152 57 31
CLOTRIMAZOLE-BETAMETHASONE 148 137 58 94
BENAZEPRIL HCL 148 144 58 69
ACTONEL 141 136 60 197
AMMONIUM LACTATE 139 125 61 125
HYDROCHLOROTHIAZIDE 138 136 62 10
PRAVASTATIN SODIUM 131 109 63 13
LANTUS SOLOSTAR 131 130 63 122
AZITHROMYCIN 128 116 65 34
SYNTHROID 127 108 66 51
SPIRIVA 126 126 67 87
EXELON 124 123 68 123
CYCLOBENZAPRINE HCL 124 100 R 68 72
MECLIZINE HCL 122 115 70 96
PAROXETINE HCL 121 113 71 62
SULINDAC 120 102 72 358
CELEBREX 119 101 73 100
ENALAPRIL MALEATE 118 118 74 38
MONTELUKAST SODIUM 112 101 75 151
FOLIC ACID 111 110 76 117
TAMSULOSIN HCL 108 107 77 33
CLORAZEPATE DIPOTASSIUM 108 108 77 236
NIFEDIPINE ER 107 97 79 75
MUPIROCIN 105 91 80 132
TEMAZEPAM 104 104 81 56
SERTRALINE HCL 104 94 81 28
FAMOTIDINE 104 94 81 70
PROCTOZONE-HC 100 99 84 209
CIPROFLOXACIN HCL 96 89 85 52
LYRICA 96 81 85 105
DOXAZOSIN MESYLATE 94 94 87 63
LANSOPRAZOLE 92 80 88 113
LACTULOSE 92 83 88 126
LISINOPRIL-HYDROCHLOROTHIAZIDE 91 85 90 26
ISOSORBIDE MONONITRATE ER 90 90 91 61
GLIPIZIDE 90 89 91 40
PEN NEEDLE 86 86 93 188
SUCRALFATE 86 81 93 237
NASONEX 84 68 95 192
POTASSIUM CHLORIDE 83 64 96 24
PROCTOSOL-HC 81 80 97 537
AGGRENOX 81 79 97 288
ACETAMINOPHEN-CODEINE 80 67 S3 99 153
VENTOLIN HFA 79 65 100 80
RAMIPRIL 78 76 101 92
GLYBURIDE 77 77 R 102 55
NAPROXEN 75 60 103 68
COMBIVENT 74 60 104 161
VESICARE 72 72 105 205
PENTOXIFYLLINE 69 69 106 149
IBANDRONATE SODIUM 68 64 107 253
BYSTOLIC 66 52 108 182
DIGOXIN 66 65 108 58
LIPITOR 66 66 108 136
SPIRONOLACTONE 66 49 108 86
TRIAMCINOLONE ACETONIDE 62 62 112 119
FINASTERIDE 61 61 113 79
METRONIDAZOLE 59 49 114 268
MICARDIS 59 59 114 336
PANTOPRAZOLE SODIUM 59 56 114 45
CITALOPRAM HBR 58 57 117 25
CYMBALTA 57 35 118 73
VYTORIN 57 52 118 216
VIAGRA 56 56 120 84
COREG CR 55 48 121 479
MICARDIS HCT 53 53 122 371
KETOCONAZOLE 53 44 122 118
LORAZEPAM 52 47 124 98
AZELASTINE HCL 51 51 125 383
WARFARIN SODIUM 51 48 125 18
BONIVA 50 44 127 328
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.